Health Sciences Acquisitions Corporation 2
HSAQ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $861 | $836 | $868 | $140 |
| % Growth | 3% | -3.7% | 520% | – |
| Cost of Goods Sold | $49 | $46 | $44 | $65 |
| Gross Profit | $812 | $790 | $824 | $75 |
| % Margin | 94.3% | 94.5% | 94.9% | 53.6% |
| R&D Expenses | $14,027 | $13,853 | $13,482 | $17,493 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7,098 | $6,264 | $6,263 | $7,858 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,125 | $20,117 | $19,745 | $25,351 |
| Operating Income | -$20,313 | -$19,327 | -$18,921 | -$26,766 |
| % Margin | -2,359.2% | -2,311.8% | -2,179.8% | -19,118.6% |
| Other Income/Exp. Net | -$515 | -$36 | $166 | $2,044 |
| Pre-Tax Income | -$20,828 | -$19,363 | -$18,755 | -$24,722 |
| Tax Expense | $0 | $0 | $0 | $1,490 |
| Net Income | -$20,828 | -$19,363 | -$18,755 | -$26,212 |
| % Margin | -2,419% | -2,316.1% | -2,160.7% | -18,722.9% |
| EPS | -0.4 | -0.5 | -0.49 | -1.66 |
| % Growth | 20% | -2% | 70.5% | – |
| EPS Diluted | -0.4 | -0.5 | -0.49 | -1.66 |
| Weighted Avg Shares Out | 52,187 | 38,393 | 38,235,409 | 36,821,042 |
| Weighted Avg Shares Out Dil | 52,187 | 38,393 | 38,235,409 | 36,821,042 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $515 | $36 | $0 | -$2,741 |
| Depreciation & Amortization | $81 | $0 | $0 | $1,408 |
| EBITDA | $81 | -$19,327 | -$18,921 | -$26,055 |
| % Margin | 9.4% | -2,311.8% | -2,179.8% | -18,611.1% |